EDGAR Filing Documents for 0001104659-22-116485

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001104659-22-116485

Filing Date

2022-11-09

Accepted

2022-11-09 16:15:30

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	tm2229768-1_s3.htm	S-3	609106
2	EXHIBIT 1.2	tm2229768d2_ex1-2.htm	EX-1.2	209317
3	EXHIBIT 4.4	tm2229768d2_ex4-4.htm	EX-4.4	369916
4	EXHIBIT 4.5	tm2229768d2_ex4-5.htm	EX-4.5	406776
5	EXHIBIT 4.6	tm2229768d2_ex4-6.htm	EX-4.6	40677
6	EXHIBIT 4.7	tm2229768d2_ex4-7.htm	EX-4.7	40587
7	EXHIBIT 5.1	tm2229768d2_ex5-1.htm	EX-5.1	31828
8	EXHIBIT 23.1	tm2229768d2_ex23-1.htm	EX-23.1	2192
9	EX-FILING FEES	tm2229768d2_ex-filingfees.htm	EX-FILING FEES	40806
10	GRAPHIC	lg_xiliotherapeutics-4c.jpg	GRAPHIC	112715
	Complete submission text file	0001104659-22-116485.txt		1903832

Mailing Address 828 WINTER STREET WALTHAM MA 02451

Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027

Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)